1. Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in
rectal cancer surgery–the clue to pelvic recurrence? Br J Surg
69:613–616
2. Campa-Thompson M, Weir R, Calcetera N, Quirke P, Carmack
S (2015) Pathologic processing of the total mesorectal excision.
Clin Colon Rectal Surg 28:43–52
3. Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J,
O’Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M,
Stephens RJ, Sebag-Montefiore D (2009) Effect of the plane of
surgery achieved on local recurrence in patients with operable
13
14. 15. (2023) 408:129
rectal cancer: a prospective study using data from the MRC
CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet
373:821–828
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local
recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread
and surgical excision. Lancet 2:996–999
Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Søreide O (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327–334
Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D, Quirke P
(2002) Rates of circumferential resection margin involvement
vary between surgeons and predict outcomes in rectal cancer
surgery. Ann Surg 235:449–457
Targarona EM, Balague C, Pernas JC, Martinez C, Berindoague R, Gich I, Trias M (2008) Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of
clinical, anatomic, and pathologic features after 3-dimensional
reconstruction of the pelvic anatomy. Ann Surg 247:642–649
Akiyoshi T, Kuroyanagi H, Oya M, Konishi T, Fukuda M, Fujimoto Y, Ueno M, Miyata S, Yamaguchi T (2009) Factors affecting the difficulty of laparoscopic total mesorectal excision with
double stapling technique anastomosis for low rectal cancer.
Surgery 146:483–489
Fung A, Trabulsi N, Morris M, Garfinkle R, Saleem A, Wexner
SD, Vasilevsky CA, Boutros M (2017) Laparoscopic colorectal
cancer resections in the obese: a systematic review. Surg Endosc
31:2072–2088
Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS,
Kim DW, Chang HJ, Kim DY, Jung KH, Kim TY, Kang GH, Chie
EK, Kim SY, Sohn DK, Kim DH, Kim JS, Lee HS, Kim JH, Oh
JH (2014) Open versus laparoscopic surgery for mid-rectal or lowrectal cancer after neoadjuvant chemoradiotherapy (COREAN
trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 15:767–774
Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH,
de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J,
Angenete E, Rosenberg J, Fuerst A, Haglind E (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer.
N Engl J Med 372:1324–1332
Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD,
Gebski VJ, Davies L, Wilson K, Hague W, Simes J (2015) Effect
of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical
trial. JAMA 314:1356–1363
Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas
M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch
M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D,
Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM,
Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic
outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA
314:1346–1355
Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H,
Yamakawa Y (2016) Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single
center. Surg Today 46:957–962
Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland
J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J (2017) Effect of
robotic-assisted vs conventional laparoscopic surgery on risk of
conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial.
JAMA 318:1569–1580
Langenbeck's Archives of Surgery
Page 9 of 9 (2023) 408:129 16. de Lacy AM, Rattner DW, Adelsdorfer C, Tasende MM, Fernández M, Delgado S, Sylla P, Martínez-Palli G (2013) Transanal
natural orifice transluminal endoscopic surgery (NOTES) rectal
resection: “down-to-up” total mesorectal excision (TME)–shortterm outcomes in the first 20 cases. Surg Endosc 27:3165–3172
17. Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses
C, Lacy AM, Bonjer HJ, Tuynman JB (2016) Clinical outcomes
and case volume effect of transanal total mesorectal excision for
rectal cancer: a systematic review. Tech Coloproctol 20:811–824
18. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP (2019)
Incidence and risk factors for anastomotic failure in 1594 patients
treated by transanal total mesorectal excision: results from the
international TaTME registry. Ann Surg 269:700–711
19. Veltcamp Helbach M, van Oostendorp SE, Koedam TWA, Knol
JJ, Stockmann H, Oosterling SJ, Vuylsteke R, de Graaf EJR,
Doornebosch PG, Hompes R, Bonjer HJ, Sietses C, Tuynman JB
(2020) Structured training pathway and proctoring; multicenter
results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands. Surg Endosc 34:192–201
20. Larsen SG, Pfeffer F, Kørner H (2019) Norwegian moratorium on
transanal total mesorectal excision. Br J Surg 106:1120–1121
21. Bravo R, Trépanier JS, Arroyave MC, Fernández-Hevia M,
Pigazzi A, Lacy AM (2017) Combined transanal total mesorectal
excision (taTME) with laparoscopic instruments and abdominal
robotic surgery in rectal cancer. Tech Coloproctol 21:233–235
22. Nikolic A, Waters PS, Peacock O, Choi CC, Rajkomar A, Heriot
AG, Smart P, Warrier S (2020) Hybrid abdominal robotic
approach with conventional transanal total mesorectal excision
(TaTME) for rectal cancer: feasibility and outcomes from a single
institution. J Robot Surg 14:633–641
23. Inoue Y, Ng JY, Chu CH, Lai YL, Huang IP, Yang SH, Chen CC
(2022) Robotic or transanal total mesorectal excision (TaTME)
approach for rectal cancer, how about both? Feasibility and outcomes from a single institution. J Robot Surg 16:149–157
24. Oshio H, Oshima Y, Yunome G, Okazaki S, Kawamura I, Ashitomi Y, Musha H, Kawai M, Motoi F (2021) Transanal total mesorectal excision and transabdominal robotic surgery for rectal cancer: a retrospective study. Ann Med Surg (Lond) 70:102902
25. Matsuda T, Yamashita K, Hasegawa H, Fujikawa M, Sakamoto
H, Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S,
Kakeji Y (2021) Clinical outcomes of transanal total mesorectal
excision using a lateral-first approach for low rectal cancer: a propensity score matching analysis. Surg Endosc 35:971–978
26. Matsuda T, Yamashita K, Hasegawa H, Takiguchi G, Urakawa N,
Yamamoto M, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji
Y (2021) Transperineal minimally invasive abdominoperineal
27. 28. 29. 30. 31. 32. 33. 34. 35. 129
resection for low rectal cancer: standardized technique and clinical outcomes. Surg Endosc 35:7236–7245
Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24:1205–1210
Sun Y, Xu H, Li Z, Han J, Song W, Wang J, Xu Z (2016) Robotic
versus laparoscopic low anterior resection for rectal cancer: a
meta-analysis. World J Surg Oncol 14:61
Crippa J, Grass F, Dozois EJ, Mathis KL, Merchea A, Colibaseanu DT, Kelley SR, Larson DW (2021) Robotic surgery for
rectal cancer provides advantageous outcomes over laparoscopic
approach: results from a large retrospective cohort. Ann Surg
274:e1218–e1222
Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti
A, Jimenez-Rodriguez RM, Gurrado A, Strippoli GFM (2018)
Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized
controlled trials. Ann Surg 267:1034–1046
Roodbeen SX, Spinelli A, Bemelman WA, Di Candido F, Cardepont M, Denost Q, D’Hoore A, Houben B, Knol JJ, MartínPérez B, Rullier E, Sands D, Setton I, Van de Steen K, Tanis PJ,
Wexner SD, Hompes R, Wolthuis AM (2021) Local recurrence
after transanal total mesorectal excision for rectal cancer: a multicenter cohort study. Ann Surg 274:359–366
Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, Liu H, Wang
Z (2016) Transanal total mesorectal excision (taTME) for rectal
cancer: a systematic review and meta-analysis of oncological and
perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer 16:380
Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk
ES, Sietses C, Tuynman JB, Lacy AM, Hanna GB, Bonjer HJ
(2016) COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low
rectal cancer. Surg Endosc 30:3210–3215
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne
J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP (2017) Transanal total mesorectal excision: international registry results of the
first 720 cases. Ann Surg 266:111–117
Muratore A, Mellano A, Marsanic P, De Simone M (2015) Transanal total mesorectal excision (taTME) for cancer located in the
lower rectum: short- and mid-term results. Eur J Surg Oncol
41:478–483
Publisher's note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
13
...